Usana Health Sciences
USNA
152 hedge funds and large institutions have $387M invested in Usana Health Sciences in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 20 closing their positions.
25% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 20
3% more funds holding
Funds holding: 147 → 152 (+5)
0.74% more ownership
Funds ownership: 55.83% → 56.57% (+0.74%)
0% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 48
4% less capital invested
Capital invested by funds: $403M → $387M (-$16.3M)
39% less call options, than puts
Call options by funds: $50K | Put options by funds: $82K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.65M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.06M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$1.79M |
| 4 |
Goldman Sachs
New York
|
+$1.6M |
| 5 |
Pzena Investment Management
New York
|
+$1.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.72M |
| 2 |
Renaissance Technologies
New York
|
-$2.18M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.09M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$1.47M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.43M |
USNA Hedge Fund Activity: Q4 2024 in Review
152 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2024, worth a combined $387M — down 4% from $403M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new USNA positions and 20 closed out — a net gain of 5 holders — while 48 added to existing stakes and 48 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $3.65M. The largest seller was UBS Group, cutting an estimated $3.72M.
- 152 institutional investors held Usana Health Sciences (USNA) as of Q4 2024, up from 147 in Q3 2024.
- Funds reported $387M of Usana Health Sciences stock for Q4 2024, down 4% quarter-over-quarter.
- 25 funds opened new Usana Health Sciences positions in Q4 2024 and 20 closed out, a net change of +5 holders.
- The largest Usana Health Sciences buyer in Q4 2024 was Royal Bank of Canada, an estimated $3.65M added.
- The largest Usana Health Sciences seller in Q4 2024 was UBS Group, an estimated $3.72M sold.
Based on aggregated 13F filings for Q4 2024.